(HealthDay News) — There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published online in the International ...

Preclinical studies have shown AT-02 is able to bind to multiple amyloid types and can induce macrophage mediated amyloid phagocytosis and removal. The Food and Drug Administration has granted Orphan ...

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

IgA nephropathy trials of new and emerging therapies that target B cell activity, the complement system, or the endothelin ...

Supply chain issues are more likely to result in drug shortages in the United States than in Canada, data suggest.

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

(HealthDay News) — Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF) in Black adults, according to a study published online in JAMA ...

A multi-pronged intervention reduced prior authorization delays and denials for patients treated in a radiation oncology department.

Clinicians treating patients with kidney disease must be aware of dental considerations to avoid potentially lethal consequences.